Moderna, Inc.
MRNA
$49.04
-$0.99-1.98%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -31.14% | -41.49% | -57.47% | -39.64% | -39.56% |
| Total Other Revenue | -6.04% | -1.57% | 3.42% | -19.46% | 4.20% |
| Total Revenue | -29.97% | -39.93% | -56.07% | -39.05% | -38.35% |
| Cost of Revenue | -34.76% | -33.41% | -28.50% | -35.89% | -33.96% |
| Gross Profit | 40.58% | 25.80% | -71.57% | 30.87% | 27.73% |
| SG&A Expenses | -11.96% | -13.29% | -17.94% | -26.13% | -26.75% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -31.09% | -30.12% | -26.74% | -34.42% | -32.90% |
| Operating Income | 32.05% | 22.08% | -28.59% | 29.39% | 27.44% |
| Income Before Tax | 7.87% | 23.26% | -34.00% | 32.02% | 29.07% |
| Income Tax Expenses | 214.29% | 217.39% | 71.32% | -102.74% | -104.20% |
| Earnings from Continuing Operations | 4.86% | 20.75% | -40.11% | 50.52% | 43.75% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 4.86% | 20.75% | -40.11% | 50.52% | 43.75% |
| EBIT | 32.05% | 22.08% | -28.59% | 29.39% | 27.44% |
| EBITDA | 35.00% | 23.88% | -37.81% | 25.37% | 22.43% |
| EPS Basic | 6.60% | 21.76% | -38.95% | 51.08% | 44.29% |
| Normalized Basic EPS | 33.71% | 23.18% | -36.35% | 31.77% | 29.98% |
| EPS Diluted | 6.67% | 21.82% | -38.25% | 51.13% | 44.36% |
| Normalized Diluted EPS | 33.73% | 23.20% | -36.10% | 31.79% | 30.00% |
| Average Basic Shares Outstanding | 1.62% | 1.30% | 1.11% | 1.05% | 0.98% |
| Average Diluted Shares Outstanding | 0.71% | 0.39% | -0.71% | 1.04% | 0.97% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |